Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
136
days
A Combination of Variants in SEPTIN9 and MSX1 Genes Leads to the Formation of Orofacial Clefts
AuthorsUdval Uuganbayar; Zarko Manojlovic; Nao Ito; Reiko Yamaguchi; Hiromasa Ninomiya; Issei S. Shimada; Chisato Yamada; Devin Feigelson; Gretchen Schulz; Allyn Auslander; Sylvia Rakotoarison; William Magee; Yutaka Hashimoto; Yoichi Kato
Affiliations1. Department of Cell Biology, Graduate School of Medical Sciences Nagoya City University Nagoya Japan; 2. Department of Urology Keck School of Medicine of USC Los Angeles California USA; 3. Operation Smile Virginia Beach Virginia USA; 4. Operation Smile Madagascar Antananarivo Madagascar; 5. Children's Hospital Los Angeles Los Angeles California USA
45
days
The Nuclear Export Signal of IκBα Drives RelB Oscillations in the Noncanonical NF ‐ κB Pathway
AuthorsTakao Seki; Shelly Davis; Shigeki Miyamoto; Taishin Akiyama; Hiroyasu Nakano; Jun‐ichiro Inoue; Katsuhide Okunishi
Affiliations1. Division of Cellular and Molecular Biology, Department of Cancer Biology The Institute of Medical Science, the University of Tokyo Tokyo Japan; 2. Laboratory for Immune Homeostasis RIKEN Center for Integrative Medical Sciences Yokohama Japan; 3. Department of Biochemistry, Faculty of Medicine Toho University Tokyo Japan; 4. Department of Oncology, University of Wisconsin Carbone Cancer Center University of Wisconsin Madison Wisconsin USA; 5. Unit of Host Defense, Faculty of Medicine Toho University Tokyo Japan; 6. Research Administration Organization Toho University Tokyo Japan
95
days
Partial Depletion of SART1 Selectively Induces Mitotic Defects and Cell Death in Cancer Cells
AuthorsHideki Yokoyama; Saito Akatsu; Kotaro Hayakawa
Affiliations1. National Institute of Technology, Ibaraki College Hitachinaka Japan
244
days
The SQSTM1 L341V Variant Associated With Sporadic ALS Promotes the Accumulation of Enlarged Ubiquitin‐Positive SQSTM1 Bodies
AuthorsKento Shimakura; Akira Oka; Haruka Yudahira; Yutaro Hama; Asako Otomo; Shinji Hadano
Affiliations1. Molecular Neuropathobiology Laboratory, Department of Physiology Tokai University School of Medicine Isehara Kanagawa Japan; 2. Department of Molecular Life Sciences Tokai University School of Medicine Isehara Kanagawa Japan; 3. The Institute of Medical Sciences Tokai University Isehara Kanagawa Japan; 4. Micro/Nano Technology Center Tokai University Hiratsuka Kanagawa Japan
158
days
FOXO1 Is Required for Growth and Viability of Cancer‐Associated Fibroblasts in Human Breast Carcinomas
AuthorsTakumi Koyama; Tetsuo Kobayashi; Yoshihiro Mezawa; Weibo Gao; Kaishi Yamada; Kazunari Yamashita; Zixu Wang; Yu Koyama; Masaaki Abe; Reo Maruyama; Liying Yang; Hiroaki Daitoku; Akiyoshi Fukamizu; Atsushi Takano; Yohei Miyagi; Tomoyuki Yokose; Toshinari Yamashita; Keisuke Sugahara; Hiroyuki Seimiya; Yataro Daigo; Akira Katakura; Akira Orimo
Affiliations1. Department of Oral Pathobiological Science and Surgery Tokyo Dental College Tokyo Japan; 2. Department of Pathology and Oncology Juntendo University Faculty of Medicine Tokyo Japan; 3. Department of Molecular Pathogenesis Juntendo University Graduate School of Medicine Tokyo Japan; 4. Division of Cancer Epigenomics, Cancer Institute Japanese Foundation for Cancer Research Tokyo Japan; 5. Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance University of Tsukuba Ibaraki Japan; 6. Research Platform Office, Institute of Medical Science The University of Tokyo Tokyo Japan; 7. Department of Medical Oncology and Cancer Center, and Center for Advanced Medicine Against Cancer Shiga University of Medical Science Otsu Japan; 8. Molecular Pathology and Genetics Division Kanagawa Cancer Center Research Institute Yokohama Japan; 9. Department of Pathology Kanagawa Cancer Center Yokohama Japan; 10. Department of Breast Surgery and Oncology Kanagawa Cancer Center Yokohama Japan; 11. Division of Molecular Biotherapy, Cancer Chemotherapy Center Japanese Foundation for Cancer Research Tokyo Japan; 12. Faculty of Health Sciences, Graduate School of Medicine Juntendo University Tokyo Japan
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days